comparemela.com

Latest Breaking News On - Diabetes obesity - Page 1 : comparemela.com

American pharma major Eli Lilly s big focus on India: Will the company s strategy work?

American pharma major Eli Lilly sees India as its launchpad for a new growth trajectory, using its new drugs for diabetes and obesity as the fuel. Will this strategic pivot work? - Issue Date: Mar 31, 2024

United statesUnited kingdomRepublic ofSheetal sapaleLilly indianSun pharmaDavida ricksZydus lifesciencesVineet guptaEli lillyNational family health surveyDrug administrationCompany india pvtEli lilly coNovo nordiskEli lilly services india pvt

Six ways to provide successful s-learning programs to healthcare professionals

Six ways to provide successful s-learning programs to healthcare professionals
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

United kingdomSucharita kunduRichard donnellyMichael kirbyTrends in urology men healthUniversity of nottinghamResearch solutionsEmeritus professorDiabetes obesitySenior content strategist

GLP-1RA Use Reduces HbA1c in Youth-Onset Type 2 Diabetes

GLP-1RA use was associated with reduced glycated hemoglobin levels across 6 months among pediatric patients with type 2 diabetes.

Drug administrationDiabetes obesity

Insulin Glargine for Dysglycemia Protects Against Cognitive Impairment

Insulin glargine for dysglycemia was associated with a reduced cognitive impairment risk after a median follow-up of 6.2 years.

Diabetes obesityOutcomes reductionInitial glargine intervention

Insulin Glargine for Dysglycemia Protects Against Cognitive Impairment

Insulin glargine for dysglycemia was associated with a reduced cognitive impairment risk after a median follow-up of 6.2 years.

Diabetes obesityOutcomes reductionInitial glargine intervention

vimarsana © 2020. All Rights Reserved.